Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Nutrition Reports
Published in: Current Nutrition Reports 4/2015

01-12-2015 | Cardiovascular Disease (JHY Wu, Section Editor)

Innovative and Collaborative Strategies to Reduce Population-Wide Sodium Intake

Authors: Karen E. Charlton, Kelly Langford, Jenny Kaldor

Published in: Current Nutrition Reports | Issue 4/2015

Login to get access

Abstract

The World Health Organization promotes salt reduction as a best-buy strategy to reduce chronic diseases, and member states have agreed to a 30 % reduction target in mean population salt intake by 2025. This systematic literature review identified a number of innovative population-level strategies, including promotion of a substitute for table salt, provision of a salt spoon to lower the amount used in home cooking and social marketing and consumer awareness campaigns on salt and health. In high-income nations, engagement with the food industry to encourage reformulation of processed foods—whether through voluntary or mandatory approaches—is key to salt reduction. Legislation of salt content in foods, although not widely adopted, can create concrete incentives and disincentives to meet targets and does not rely on individuals to change their behaviour. The important role of advocacy and lobbying to change the food supply is undisputed.
Literature
1.
He FJ, MacGregor GA. Reducing population salt intake worldwide: from evidence to implementation. Prog Cardiovasc Dis. 2010;52(5):363–82.CrossRefPubMed
2.
Webster J et al. The development of a national salt reduction strategy for Australia. Asia Pac J Clin Nutr. 2009;18(3):303–9.PubMed
3.
Strazzullo P, Cairella G, Campanozzi A, Carcea M, Galeone D, Galletti F, et al. Population based strategy for dietary salt intake reduction: Italian initiatives in the European framework. Nutr Metab Cardiovasc Dis. 2012;22(3):161–6.CrossRefPubMed
4.•
Charlton K, Webster J, Kowal P. To legislate or not to legislate? A comparison of the UK and South African approaches to the development and implementation of salt reduction programs. Nutrients. 2014;6(9):3672–95. This paper compares the process of developing salt reduction strategies in the UK, the country that has made the most progress on salt reduction, and South Africa, the first country to pass legislation for salt levels in a range of processed foods. Valuable lessons for other countries are provided. PubMedCentralCrossRefPubMed
5.
World Health Organization. From burden to “best buys”: reducing the economic impact of NCDs in low- and middle-income countries. Geneva: World Economic Forum; 2011.
6.
7.
Asaria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet. 2007;2044–2053:370.
8.
Powles J, Fahimi S, Micha R, Khatibzadeh S, Shi P, Ezzati M, et al. Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open. 2013;3:e003733.PubMedCentralCrossRefPubMed
9.
10.
Webster JL, Dunford EK, Hawkes C, Neal BC. Salt reduction initiatives around the world. J Hypertens. 2011;29:1043–50.CrossRefPubMed
11.
He FJ, Jenner KH, MacGregor GA. WASH—World Action on Salt and Health. Kidney Int. 2010;78(8):745–53.CrossRefPubMed
12.
Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010;362:590–9.PubMedCentralCrossRefPubMed
13.
Anderson CAM JR, Kris-Etherton PM, Miller EA. Commentary on making sense of the science of sodium. Nutr Today. 2015;50(2):66–71.CrossRef
14.
15.••
Trieu K, Neal B, Hawkes C, Dunford E, Campbell N, Rodriguez-Fernandez R, et al. Salt reduction initiatives around the world—a systematic review of progress towards the global target. PLoS ONE 2015; 10(7). Very recent update of the situation of salt reduction strategies adopted by different countries globally.
16.
Institute of Medicine. Sodium intake in populations: assessment of evidence. Washington: National Academies Press; 2013.
17.
Institute of Medicine. Dietary reference intakes: water, potassium, sodium, chloride, and sulfate. Washington: National Academies Press; 2004.
18.
Thomas MC, Forsblom MJ, et al. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care. 2011;34:861–6.PubMedCentralCrossRefPubMed
19.
O’Donnell MJ. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med. 2014;371:612–23.CrossRefPubMed
20.
Stolarz-Skrzypek K, Kuznetsova T, Thijs L, European project on genes in hypertension (EPOGH) investigators, et al. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA. 2011;305:1777Y1785.CrossRef
21.
National Health and Medical Research Council. How to review the evidence: systematic identification and review of the scientific literature. Canberra: NHMRC; 2000.
22.
Mozaffarian D, Fahimi S, Singh GM, Micha R, Khatibzadeh S, Engell RE, et al. Global sodium consumption and death from cardiovascular causes. N Engl J Med. 2014;37(7):624–34.CrossRef
23.
Bernabe-Ortiz A, et al. Launching a salt substitute to reduce blood pressure at the population level: a cluster randomized stepped wedge trial in Peru. Trials 2014;15(1).
24.
Li N et al. Salt substitution: a low-cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial. J Hypertens. 2007;25(10):2011–8.CrossRef
25.••
Zhou B et al. Long-term effects of salt substitution on blood pressure in a rural north Chinese population. J Hum Hypertens. 2013;27(7):427–33. High-quality randomized controlled trial of relatively long duration (2 years) that shows benefit in both hypertensive and normotensive individuals. CrossRefPubMed
26.
Fulgoni VL et al. Sodium intake in US ethnic subgroups and potential impact of a new sodium reduction technology: NHANES dietary modeling. Nutr J. 2014;13:9.CrossRef
27.
Land MA et al. Protocol for the implementation and evaluation of a community-based intervention seeking to reduce dietary salt intake in Lithgow, Australia. BMC Public Health. 2014;14:7.CrossRef
28.
29.
Anderson CA, Appel LJ, Okuda N, Brown IJ, Chan Q, et al. Dietary sources of sodium in China, Japan, the United Kingdom, and the United States, women and men aged 40 to 59 years: the INTERMAP study. J Am Diet Assoc. 2010;110:736–45.PubMedCentralCrossRefPubMed
30.
Wenlan D, Weiwei L, Min K, Yuzhong D, Huilai M, et al. Survey on the situation of salt-restriction-spoon using among urban residents in Beijing in 2011. Chin J Prev Med. 2011;10:952–3.
31.••
Chen J et al. Salt-restriction-spoon improved the salt intake among residents in China. PLoS ONE. 2013;8(11):e78963. A randomized controlled trial that demonstrated the effectiveness of a simple behavioural intervention on reduced salt intake, through changes in food preparation. PubMedCentralCrossRefPubMed
32.
McLean R, Hoek J, Hedderley D. Effects of alternative label formats on choice of high- and low-sodium products in a New Zealand population sample. Public Health Nutr. 2012;15(5):783–91.CrossRefPubMed
33.
Webster J. Drop the Salt! Assessing the impact of a public health advocacy strategy on Australian government policy on salt. Public Health Nutr. 2014;17(1):212–8.CrossRefPubMed
34.
Elliott T, Trevena H, Sacks G, Dunford E, et al. A systematic interim assessment of the Australian government’s food and health dialogue. Med J Aust. 2014;200(2):92–5.CrossRefPubMed
35.•
Shankar B, Brambila-Macias J, Traill B, Mazzocchi M, Capacci S. An evaluation of the UK Food Standards Agency’s salt campaign. Health Econ. 2013;22:243–50. One of the few rigorous evaluations of the UK salt reduction strategy that controls for potential influences of changes in food prices, income and education and demographic factors. CrossRefPubMed
36.
Wyness LA, Butriss JL, Stanner SA. Reducing the population’s sodium intake: the UK food standards agency’s salt reduction programme. Public Health Nutr. 2012;15:254–61.CrossRefPubMed
37.
Smith-Spangler CM, Juusola JL, Enns EA, Owens DK, Garber AM. Population strategies to decrease sodium intake and the burden of cardiovascular disease. Ann Intern Med. 2010;152:481–7.CrossRefPubMed
38.
39.
40.
He FJ, MacGregor GA. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens. 2009;23:363–84.CrossRefPubMed
41.
Pietinen P, Valsta L, Hirvonen T, Sinkko H. Labelling the salt content in foods: a useful tool in reducing sodium intake in Finland. Public Health Nutr. 2008;11(4):335–40.CrossRefPubMed
42.
43.
Li N, Yan L, Niu W, Labarthe D, Feng X, Shi J, et al. A large-scale cluster randomized trial to determine the effects of community-based dietary sodium reduction- the China rural health initiative sodium reduction study. Am Heart J. 2013;166(5):815–22.PubMedCentralCrossRefPubMed
44.
Charlton KE, Steyn K, Levitt NS, Peer N, Jonathan D, Gogela T, et al. A food-based dietary strategy lowers blood pressure in a low socio-economic setting: a randomised study in South Africa. Public Health Nutr. 2008;11(12):1397–406.CrossRefPubMed
45.
Braschi A, Gill L, Naismith DJ. Partial substitution of sodium with potassium in white bread: feasibility and bioavailability. Int J Food Sci Nutr. 2009;60(6):507–21.CrossRefPubMed
46.
Charlton KE, MacGregor E, Vorster NH, Levitt NS, Steyn K. Partial replacement of NaCl can be achieved with potassium, magnesium and calcium salts in brown bread. Int J Food Sci Nutr. 2007;58(7):508–21.CrossRefPubMed
47.
Webster J et al. Target salt 2025: a global overview of national programs to encourage the food industry to reduce salt in foods. Nutrients. 2014;6(8):3274–87.PubMedCentralCrossRefPubMed
48.
Trevena H, Neal B, Dunford E, Wu JH. An evaluation of the effects of the Australian food and health dialogue targets on the sodium content of bread, breakfast cereals and processed meats. Nutrients. 2014;6(9):3802–17.PubMedCentralCrossRefPubMed
49.
Gostin LO. Public health law—power, duty, restraint. 2nd ed. Berkeley: University of California Press; 2008.
50.
Magnusson RS, Patterson D. The role of law and governance reform in the global response to non-communicable diseases. Glob Health. 2014;10:44.CrossRef
51.
Burris S, Anderson ED. Legal regulation of health-related behavior: a half-century of public health law research. Ann Rev Law Soc Sci. 2013;9:95–117.CrossRef
52.
53.
Brownell KD et al. Personal responsibility and obesity: a constructive approach to a controversial issue. Health Aff. 2010;29(3):378–86.CrossRef
54.
Regulations relating to the reduction of sodium in certain foodstuffs and related matters, Regulation No. R. 214 under the Foodstuffs, Cosmetics and Disinfectants Act 1972 (South Africa), 20 March 2013; and Alimentos, Ley 26.905, Consumo de sodio: Valores Máximos, 13 November 2013.
55.
Cappuccio FP et al. Policy options to reduce population salt intake. BMJ. 2011;343:4995.CrossRef
56.
He F, Brinsden H, MacGregor G. Salt reduction in the United Kingdom: a successful experiment in public health. J Hum Hypertens. 2014;28(6):345–52.CrossRefPubMed
57.
Panjwani C, Caraher M. The public health responsibility deal: brokering a deal for public health, but on whose terms? Health Policy. 2014;114:163–73.CrossRefPubMed
58.
Blewett N et al. Labelling logic: review of food labelling law and policy. Canberra: Commonwealth of Australia; 2011.
59.
Magnusson R, Reeve B. ‘Steering’ private regulation? A new strategy for reducing population salt intake in Australia. Sydney Law Rev. 2014;36(2):255–89.
60.
Jewell J, Hawkes C, Allen K. Law and obesity prevention: addressing some key questions for the public health community. WCRF International; 2013.
61.
62.
Webster J, Snowdon W, Moodie M, Viali S, Schultz J, Bell C. Cost-effectiveness of reducing salt intake in the Pacific Islands: protocol for a before and after intervention study. BMC Public Health. 2014;14:107–14.PubMedCentralCrossRefPubMed
Metadata
Title
Innovative and Collaborative Strategies to Reduce Population-Wide Sodium Intake
Authors
Karen E. Charlton
Kelly Langford
Jenny Kaldor
Publication date
01-12-2015
Publisher
Springer US
Published in
Current Nutrition Reports / Issue 4/2015
Electronic ISSN: 2161-3311
DOI
https://doi.org/10.1007/s13668-015-0138-2

Other articles of this Issue 4/2015

Current Nutrition Reports 4/2015 Go to the issue

Cardiovascular Disease (JHY Wu, Section Editor)

The Efficacy of Quercetin in Cardiovascular Health

Public Health and Translational Medicine (PW Franks and R Landberg, Section Editors)

Application of Metabolomics to Assess Effects of Controlled Dietary Interventions

Diabetes and Obesity (L Qi, Section Editor)

Obesity, Diet and the Gut Microbiota

Public Health and Translational Medicine (PW Franks and R Landberg, Section Editors)

Metabolomics for Improved Understanding and Prediction of Cardiometabolic Diseases—Recent Findings from Human Studies

Public Health and Translational Medicine (PW Franks and R Landberg, Section Editors)

Whole-Blood Gene Expression Profiles in Large-Scale Epidemiological Studies: What Do They Tell?

Cardiovascular Disease (JHY Wu, Section Editor)

Is a Cardio-Protective Diet Sustainable? A Review of the Synergies and Tensions Between Foods That Promote the Health of the Heart and the Planet
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits